Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Agios Pharmaceuticals completes $113mm IPO

Executive Summary

Agios Pharmaceuticals Inc. (studying cellular metabolism as it relates to serious diseases) netted $113mm through its initial public offering. The company sold 6.8mm common shares (including the overallotment) at $18, a big jump from the range it had set a few weeks ago of 5mm shares at $14-16 each.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies